Comments are not available on this story.
Send questions/comments to the editors.
Rubber stoppers are placed onto filled vials of remdesivir at a Gilead manufacturing site in the U.S. HHS will likely send the first shipment of the 500,000 treatment courses in about two weeks, a senior Health and Human Services official said.
Comments are not available on this story.
Send questions/comments to the editors.